Ben Van Handel, PhD

CarthroniX, Inc.
Lancaster, CA, United States

Co-founder and CSO of CarthroniX, Inc.

Disclosure information not submitted.

Presentation(s):

• 1888: Novel Small Molecule Modulator of the gp130 Receptor Shows Dose-dependent Therapeutic Efficacy in a Canine Model of Osteoarthritis

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time